Abstract
Forty children with steroid-dependent idiopathic nephrotic syndrome and signs of steroid toxicity were randomly assigned to receive either cyclosporin 6 mg/kg body wt. per day for 3 months and at tapering doses over the next 3 months or chlorambucil at a cumulative dose of 8 mg/kg body wt. The two groups of patients did not differ significantly in sex distribution, age of onset of disease, duration of disease, number of relapses and histological findings. Of the 20 patients treated with cyclosporin, 4 relapsed before or on discontinuation of prednisone, 7 relapsed when the initial dose of cyclosporin was tapered, and 8 after withdrawal of cyclosporin. Of the 20 patients treated with chlorambucil, 14 relapsed while 6 were still in remission 27–49 months after completion of the treatment course. Thus the actuarial remission rate at 2 years was 45% after a course of chlorambucil compared with only 5% after a 3-month course of cyclosporin. We believe that children with steroid-dependent idiopathic nephrotic syndrome should be treated with a course of chlorambucil before resorting to cyclosporin.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Broyer M (1988) La néphrose idiopathique et son traitement. Arch Fr Pediatr 45:1–4
Barratt TM, Osofsky FG, Berkowsky A, Soothill JF, Kay R (1975) Cyclophosphamide treatment in steroid sensitive nephrotic syndrome of childhood. Lancet I:55–58
Grupe WE, Makker SP, Ingelfinger JR (1976) Chlorambucil treatment of frequently relapsing nephrotic syndrome. N Engl J Med 295:746–749
Pennisi AJ, Grushkin CM, Lieberman E (1976) Cyclophosphamide in the treatment of idiopathic nephrotic syndrome. Pediatrics 57:948–951
Cameron JS, Chantler C, Ogg CS, White RHR (1974) Long term stability or remission in nephrotic syndrome after treatment with cyclophosphamide. B M J 4:7–14
McDonald J, Murphy AV, Arneil GC (1974) Long term assessment of cyclophosphamide therapy for nephrosis. Lancet II:980–982
Baluarte HJ, Hiner L, Gruskin AB (1978) Chlorambucil dosage in frequently relapsing nephrotic syndrome: a controlled clinical trial. J Pediatr 92:295–298
Arbeitsgemeinschaft für Pädiatrische Nephrologie (1982) Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence. N Engl J Med 306:451–454
Arbeitsgemeinschaft für Pädiatrische Nephrologie (1987) Cyclophosphamide treatment of steroid dependent nephrotic syndrome comparison of eigth week with 12 week course. Arch Dis Child 62:1102–1106
Williams SA, Makker SP, Ingelfinger JR, Grupe WE (1989) Long term evaluation of chlorambucil plus prednisone in idiopathic nephrotic syndrome of childhood. N Engl J Med 302:929–933
Penso J, Lippe B, Ehrlich R, Smith FC (1974) Testicular function in prepubertal and pubertal male patients treated with cyclophosphamide for nephrotic syndrome. J Pediatr 84:831–836
Guesry P, Lenoir G, Broyer M (1978) Gonadal effects of chlorambucil given to prepubertal and pubertal boys for nephrotic syndrome. J Pediatr 92:299–303
Hsu AC, Folami AO, Bain J, Rance CP (1979) Gonadal functions in males treated with cyclophosphamide for nephrotic syndrome. Fertil Steril 31:173–177
Callis L, Nieto J, Vila A, Rende J (1980) Chlorambucil treatment in minimal lesion nephrotic syndrome: a reappraisal of its gonadal toxicity. J Pediatr 97:653–656
Trompeter RS, Evans PR, Barratt TM (1981) Gonadal function in boys with steroid responsive nephrotic syndrome treated with cyclophosphamide for short periods. Lancet I:1177–1180
Capodicasa G, De Santo NG, Nuzzi F, Giordano C (1986) Cyclosporin A in nephrotic syndrome of childhood: a 14 month experience. Int J Pediatr Nephrol 7:69–72
Lagrue G, Laurent J, Belghiti D, Robeva R (1986) Cyclosporin and idiopathic nephrotic syndrome. Lancet II:692–693
Niaudet P, Habib R, Tête MJ, Hinglais N, Broyer M (1987) Cyclosporine in the treatment of idiopathic nephrotic syndrome in children. Pediatr Nephrol 1:566–573
Brodehl J, Hoyer PF, Oemar BS, Heimchen U, Wonigeit K (1988) Cyclosporin treatment of nephrotic syndrome in children. Transplant Proc 20 [Suppl 4]:269–274
Mentser M, Shannon B, Mahan JD (1988) Cyclosporin treatment of frequently relapsing minimal change nephrotic syndrome in children. Response to therapy and evidence for a T-cell abnormality. Kidney Int 33:329
Tejani A, Butt K, Trachtman H, Suthanthiran M, Rosenthal CJ, Khawar MR (1988) Cyclosporin A induced remission in relapsing nephrotic syndrome in children. Kidney Int 33:729–734
Meyrier A and Collaborative Group of the Société de Néphrologie (1989) Cyclosporin in the treatment of nephrosis. Am J Nephrol 9 [Suppl 1]:65–71
Kitano Y, Yoshikawa N, Tanaka R, Nakamura H, Nimomiya M, Ito H (1990) Cyclosporin treatment in children with steroid-dependent nephrotic syndrome. Pediatr Nephrol 4:474–477
Myers BD (1986) Cyclosporin nephrotoxicity. Kidney Int 30:964–976
Niaudet P, Broyer M, Habib R (1990) Evaluation of nephrotoxicity by sequential biopsies in 38 children with idiopathic nephrosis treated with cyclosporin A. Kidney Int 37:260
Author information
Authors and Affiliations
Consortia
Rights and permissions
About this article
Cite this article
Niaudet, P., French Society of Paediatric Nephrology. Comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: a multicentre randomized controlled trial. Pediatr Nephrol 6, 1–3 (1992). https://doi.org/10.1007/BF00856817
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00856817